223 related articles for article (PubMed ID: 35774067)
1. Interleukin-10-Modified Adipose-Derived Mesenchymal Stem Cells Prevent Hypertrophic Scar Formation via Regulating the Biological Characteristics of Fibroblasts and Inflammation.
Xie F; Teng L; Lu J; Xu J; Zhang C; Yang L; Ma X; Zhao M
Mediators Inflamm; 2022; 2022():6368311. PubMed ID: 35774067
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of Pathological Phenotype of Hypertrophic Scar Fibroblasts Via Coculture with Adipose-Derived Stem Cells.
Deng J; Shi Y; Gao Z; Zhang W; Wu X; Cao W; Liu W
Tissue Eng Part A; 2018 Mar; 24(5-6):382-393. PubMed ID: 28562226
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-10 modified bone marrow mesenchymal stem cells prevent hypertrophic scar formation by inhibiting inflammation.
Xie F; Teng L; Xu J; Lu J; Zhang C; Yang L; Ma X; Zhao M
Pharmazie; 2020 Nov; 75(11):571-575. PubMed ID: 33239131
[TBL] [Abstract][Full Text] [Related]
4. IL-10 alleviates lipopolysaccharide-induced skin scarring via IL-10R/STAT3 axis regulating TLR4/NF-κB pathway in dermal fibroblasts.
Shi J; Shi S; Xie W; Zhao M; Li Y; Zhang J; Li N; Bai X; Cai W; Hu X; Hu D; Han J; Guan H
J Cell Mol Med; 2021 Feb; 25(3):1554-1567. PubMed ID: 33410606
[TBL] [Abstract][Full Text] [Related]
5. Exosomes derived from human adipose mesenchymal stem cells attenuate hypertrophic scar fibrosis by miR-192-5p/IL-17RA/Smad axis.
Li Y; Zhang J; Shi J; Liu K; Wang X; Jia Y; He T; Shen K; Wang Y; Liu J; Zhang W; Wang H; Zheng Z; Hu D
Stem Cell Res Ther; 2021 Mar; 12(1):221. PubMed ID: 33789737
[TBL] [Abstract][Full Text] [Related]
6. Bone marrow concentrate-induced mesenchymal stem cell conditioned medium facilitates wound healing and prevents hypertrophic scar formation in a rabbit ear model.
Hu CH; Tseng YW; Chiou CY; Lan KC; Chou CH; Tai CS; Huang HD; Hu CW; Liao KH; Chuang SS; Yang JY; Lee OK
Stem Cell Res Ther; 2019 Aug; 10(1):275. PubMed ID: 31462299
[TBL] [Abstract][Full Text] [Related]
7. Bone marrow derived mesenchymal stem cells inhibit the proliferative and profibrotic phenotype of hypertrophic scar fibroblasts and keloid fibroblasts through paracrine signaling.
Fang F; Huang RL; Zheng Y; Liu M; Huo R
J Dermatol Sci; 2016 Aug; 83(2):95-105. PubMed ID: 27211019
[TBL] [Abstract][Full Text] [Related]
8. Lapachol suppresses cell proliferation and secretion of interleukin-6 and plasminogen activator inhibitor-1 of fibroblasts derived from hypertrophic scars.
Matsui T; Ito C; Oda M; Itoigawa M; Yokoo K; Okada T; Furukawa H
J Pharm Pharmacol; 2011 Jul; 63(7):960-6. PubMed ID: 21635262
[TBL] [Abstract][Full Text] [Related]
9. Adipose-Derived Mesenchymal Stem Cells Alleviate Hypertrophic Scar by Inhibiting Bioactivity and Inducing Apoptosis in Hypertrophic Scar Fibroblasts.
Li S; Yang J; Sun J; Chen M
Cells; 2022 Dec; 11(24):. PubMed ID: 36552789
[No Abstract] [Full Text] [Related]
10. Hepatocyte Growth Factor Secreted from Human Adipose-Derived Stem Cells Inhibits Fibrosis in Hypertrophic Scar Fibroblasts.
Ma J; Yan X; Lin Y; Tan Q
Curr Mol Med; 2020; 20(7):558-571. PubMed ID: 31903876
[TBL] [Abstract][Full Text] [Related]
11. Platycodin D inhibits the proliferation and migration of hypertrophic scar-derived fibroblasts and promotes apoptosis through a caspase-dependent pathway.
Yu Z; Li Y; Fu R; Xue Y; Zhao D; Han D
Arch Dermatol Res; 2023 Jul; 315(5):1257-1267. PubMed ID: 36526799
[TBL] [Abstract][Full Text] [Related]
12. Exosome Derived from Mesenchymal Stem Cells Alleviates Hypertrophic Scar by Inhibiting the Fibroblasts via TNFSF-13/HSPG2 Signaling Pathway.
Zhang H; Zang C; Zhao W; Zhang L; Liu R; Feng Z; Wu J; Cui R
Int J Nanomedicine; 2023; 18():7047-7063. PubMed ID: 38046235
[TBL] [Abstract][Full Text] [Related]
13. Exosomes from human adipose-derived mesenchymal stem cells inhibit production of extracellular matrix in keloid fibroblasts via downregulating transforming growth factor-β2 and Notch-1 expression.
Li J; Li Z; Wang S; Bi J; Huo R
Bioengineered; 2022 Apr; 13(4):8515-8525. PubMed ID: 35333672
[TBL] [Abstract][Full Text] [Related]
14. Adipose-derived mesenchymal stem cells inhibit cell proliferation and migration and suppress extracellular matrix synthesis in hypertrophic-scar and keloid fibroblasts.
Xie F; Teng L; Xu J; Lu J; Zhang C; Yang L; Ma X; Zhao M
Exp Ther Med; 2021 Feb; 21(2):139. PubMed ID: 33456506
[TBL] [Abstract][Full Text] [Related]
15. Chyle Fat-Derived Stem Cells Conditioned Medium Inhibits Hypertrophic Scar Fibroblast Activity.
Chen J; Li Z; Huang Z; Liang L; Chen M
Ann Plast Surg; 2019 Sep; 83(3):271-277. PubMed ID: 31149905
[TBL] [Abstract][Full Text] [Related]
16. Exosomes secreted by adipose-derived mesenchymal stem cells regulate type I collagen metabolism in fibroblasts from women with stress urinary incontinence.
Liu X; Wang S; Wu S; Hao Q; Li Y; Guo Z; Wang W
Stem Cell Res Ther; 2018 Jun; 9(1):159. PubMed ID: 29895333
[TBL] [Abstract][Full Text] [Related]
17. Cryptotanshinone downregulates the profibrotic activities of hypertrophic scar fibroblasts and accelerates wound healing: A potential therapy for the reduction of skin scarring.
Li Y; Shi S; Gao J; Han S; Wu X; Jia Y; Su L; Shi J; Hu D
Biomed Pharmacother; 2016 May; 80():80-86. PubMed ID: 27133042
[TBL] [Abstract][Full Text] [Related]
18. PTEN hinders the formation of scars by regulating the levels of proteins in the extracellular matrix and promoting the apoptosis of dermal fibroblasts through Bcl-xL.
Li S; Wang Y; Chen Y; Zhang H; Shen K; Guan H
Arch Biochem Biophys; 2024 Mar; 753():109912. PubMed ID: 38325773
[TBL] [Abstract][Full Text] [Related]
19. Anti-fibrotic actions of interleukin-10 against hypertrophic scarring by activation of PI3K/AKT and STAT3 signaling pathways in scar-forming fibroblasts.
Shi J; Li J; Guan H; Cai W; Bai X; Fang X; Hu X; Wang Y; Wang H; Zheng Z; Su L; Hu D; Zhu X
PLoS One; 2014; 9(5):e98228. PubMed ID: 24878845
[TBL] [Abstract][Full Text] [Related]
20. [Effects of silencing Smad ubiquitination regulatory factor 2 on the function of human hypertrophic scar-derived fibroblasts].
Zhang Z; Kuang F; Liu CL; Chen B; Tang WB; Li XJ
Zhonghua Shao Shang Za Zhi; 2017 Mar; 33(3):145-151. PubMed ID: 28316163
[No Abstract] [Full Text] [Related]
[Next] [New Search]
